检索结果 - Elbez, Yedid
- Showing 1 - 17 results of 17
-
1
-
2
Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study 由 Durez, Patrick, Westhovens, Rene, Baeke, Femke, Elbez, Yedid, Robert, Sofie, Ahmad, Harris A.
出版 2022Text -
3
-
4
-
5
-
6
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting 由 Alten, Rieke, Burkhardt, Harald, Feist, Eugen, Krüger, Klaus, Rech, Juergen, Rubbert-Roth, Andrea, Voll, Reinhard E., Elbez, Yedid, Rauch, Christiane
出版 2018Text -
7
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept 由 Ahmad, Harris A., Baker, Joshua F., Conaghan, Philip G., Emery, Paul, Huizinga, Thomas W. J., Elbez, Yedid, Banerjee, Subhashis, Østergaard, Mikkel
出版 2022Text -
8
Vitamin K antagonists with or without long‐term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleed... 由 Lemesle, Gilles, Ducrocq, Gregory, Elbez, Yedid, Van Belle, Eric, Goto, Shinya, Cannon, Christopher P., Bauters, Christophe, Bhatt, Deepak L., Steg, Philippe Gabriel
出版 2017Text -
9
Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study 由 Alten, Rieke, Mariette, Xavier, Lorenz, Hanns-Martin, Galeazzi, Mauro, Cantagrel, Alain, Nüßlein, Hubert G, Chartier, Melanie, Elbez, Yedid, Rauch, Christiane, Le Bars, Manuela
出版 2017Text -
10
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial 由 McInnes, Iain B, Ferraccioli, Gianfranco, D'Agostino, Maria-Antonietta, Le Bars, Manuela, Banerjee, Subhashis, Ahmad, Harris A, Elbez, Yedid, Mease, Philip J
出版 2019Text -
11
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry 由 Vidal-Petiot, Emmanuelle, Sorbets, Emmanuel, Bhatt, Deepak L, Ducrocq, Gregory, Elbez, Yedid, Ferrari, Roberto, Ford, Ian, Tardif, Jean-Claude, Tendera, Michal, Fox, Kim M, Steg, Philippe Gabriel
出版 2018Text -
12
Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry 由 Abtan, Jérémie, Bhatt, Deepak L., Elbez, Yedid, Sorbets, Emmanuel, Eagle, Kim, Ikeda, Yasuo, Wu, David, Hanson, Mary E., Hannachi, Hakima, Singhal, Puneet K., Steg, Philippe Gabriel, Ducrocq, Gregory
出版 2016Text -
13
Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry 由 Abtan, Jérémie, Bhatt, Deepak L., Elbez, Yedid, Sorbets, Emmanuel, Eagle, Kim, Reid, Christopher M., Baumgartner, Iris, Wu, David, Hanson, Mary E., Hannachi, Hakima, Singhal, Puneet K., Steg, Philippe Gabriel, Ducrocq, Gregory
出版 2017Text -
14
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study 由 Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
出版 2016Text -
15
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry 由 Kumbhani, Dharam J., Steg, Ph. Gabriel, Cannon, Christopher P., Eagle, Kim A., Smith, Sidney C., Goto, Shinya, Ohman, E. Magnus, Elbez, Yedid, Sritara, Piyamitr, Baumgartner, Iris, Banerjee, Subhash, Creager, Mark A., Bhatt, Deepak L.
出版 2014Text -
16
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry 由 Sorbets, Emmanuel, Fox, Kim M, Elbez, Yedid, Danchin, Nicolas, Dorian, Paul, Ferrari, Roberto, Ford, Ian, Greenlaw, Nicola, Kalra, Paul R, Parma, Zofia, Shalnova, Svetlana, Tardif, Jean-Claude, Tendera, Michal, Zamorano, José Luis, Vidal-Petiot, Emmanuelle, Steg, Philippe Gabriel
出版 2020Text -
17
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial 由 Thaçi, Diamant, Strober, Bruce, Gordon, Kenneth B., Foley, Peter, Gooderham, Melinda, Morita, Akimichi, Papp, Kim A., Puig, Lluís, Menter, M. Alan, Colombo, Matthew J., Elbez, Yedid, Kisa, Renata M., Ye, June, Napoli, Andrew A., Wei, Lan, Banerjee, Subhashis, Merola, Joseph F., Gottlieb, Alice B.
出版 2022Text